Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies
Abstract Transcriptional dysregulation is a hallmark of cancer initiation and progression, driven by genetic and epigenetic alterations. Enhancer reprogramming has emerged as a pivotal driver of carcinogenesis, with cancer cells often relying on aberrant transcriptional programs. The advent of high-...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-03-01
|
| Series: | Cell Death Discovery |
| Online Access: | https://doi.org/10.1038/s41420-025-02366-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849761904318218240 |
|---|---|
| author | Jinshou Yang Feihan Zhou Xiyuan Luo Yuan Fang Xing Wang Xiaohong Liu Ruiling Xiao Decheng Jiang Yuemeng Tang Gang Yang Lei You Yupei Zhao |
| author_facet | Jinshou Yang Feihan Zhou Xiyuan Luo Yuan Fang Xing Wang Xiaohong Liu Ruiling Xiao Decheng Jiang Yuemeng Tang Gang Yang Lei You Yupei Zhao |
| author_sort | Jinshou Yang |
| collection | DOAJ |
| description | Abstract Transcriptional dysregulation is a hallmark of cancer initiation and progression, driven by genetic and epigenetic alterations. Enhancer reprogramming has emerged as a pivotal driver of carcinogenesis, with cancer cells often relying on aberrant transcriptional programs. The advent of high-throughput sequencing technologies has provided critical insights into enhancer reprogramming events and their role in malignancy. While targeting enhancers presents a promising therapeutic strategy, significant challenges remain. These include the off-target effects of enhancer-targeting technologies, the complexity and redundancy of enhancer networks, and the dynamic nature of enhancer reprogramming, which may contribute to therapeutic resistance. This review comprehensively encapsulates the structural attributes of enhancers, delineates the mechanisms underlying their dysregulation in malignant transformation, and evaluates the therapeutic opportunities and limitations associated with targeting enhancers in cancer. |
| format | Article |
| id | doaj-art-b5269109a91b424bb4fc206f4d853ff1 |
| institution | DOAJ |
| issn | 2058-7716 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Cell Death Discovery |
| spelling | doaj-art-b5269109a91b424bb4fc206f4d853ff12025-08-20T03:05:52ZengNature Publishing GroupCell Death Discovery2058-77162025-03-0111113010.1038/s41420-025-02366-3Enhancer reprogramming: critical roles in cancer and promising therapeutic strategiesJinshou Yang0Feihan Zhou1Xiyuan Luo2Yuan Fang3Xing Wang4Xiaohong Liu5Ruiling Xiao6Decheng Jiang7Yuemeng Tang8Gang Yang9Lei You10Yupei Zhao11Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical SciencesDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical SciencesDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical SciencesDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical SciencesDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical SciencesDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical SciencesDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical SciencesDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical SciencesDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical SciencesDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical SciencesDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical SciencesDepartment of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical SciencesAbstract Transcriptional dysregulation is a hallmark of cancer initiation and progression, driven by genetic and epigenetic alterations. Enhancer reprogramming has emerged as a pivotal driver of carcinogenesis, with cancer cells often relying on aberrant transcriptional programs. The advent of high-throughput sequencing technologies has provided critical insights into enhancer reprogramming events and their role in malignancy. While targeting enhancers presents a promising therapeutic strategy, significant challenges remain. These include the off-target effects of enhancer-targeting technologies, the complexity and redundancy of enhancer networks, and the dynamic nature of enhancer reprogramming, which may contribute to therapeutic resistance. This review comprehensively encapsulates the structural attributes of enhancers, delineates the mechanisms underlying their dysregulation in malignant transformation, and evaluates the therapeutic opportunities and limitations associated with targeting enhancers in cancer.https://doi.org/10.1038/s41420-025-02366-3 |
| spellingShingle | Jinshou Yang Feihan Zhou Xiyuan Luo Yuan Fang Xing Wang Xiaohong Liu Ruiling Xiao Decheng Jiang Yuemeng Tang Gang Yang Lei You Yupei Zhao Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies Cell Death Discovery |
| title | Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies |
| title_full | Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies |
| title_fullStr | Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies |
| title_full_unstemmed | Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies |
| title_short | Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies |
| title_sort | enhancer reprogramming critical roles in cancer and promising therapeutic strategies |
| url | https://doi.org/10.1038/s41420-025-02366-3 |
| work_keys_str_mv | AT jinshouyang enhancerreprogrammingcriticalrolesincancerandpromisingtherapeuticstrategies AT feihanzhou enhancerreprogrammingcriticalrolesincancerandpromisingtherapeuticstrategies AT xiyuanluo enhancerreprogrammingcriticalrolesincancerandpromisingtherapeuticstrategies AT yuanfang enhancerreprogrammingcriticalrolesincancerandpromisingtherapeuticstrategies AT xingwang enhancerreprogrammingcriticalrolesincancerandpromisingtherapeuticstrategies AT xiaohongliu enhancerreprogrammingcriticalrolesincancerandpromisingtherapeuticstrategies AT ruilingxiao enhancerreprogrammingcriticalrolesincancerandpromisingtherapeuticstrategies AT dechengjiang enhancerreprogrammingcriticalrolesincancerandpromisingtherapeuticstrategies AT yuemengtang enhancerreprogrammingcriticalrolesincancerandpromisingtherapeuticstrategies AT gangyang enhancerreprogrammingcriticalrolesincancerandpromisingtherapeuticstrategies AT leiyou enhancerreprogrammingcriticalrolesincancerandpromisingtherapeuticstrategies AT yupeizhao enhancerreprogrammingcriticalrolesincancerandpromisingtherapeuticstrategies |